Literature DB >> 11720888

Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa.

B Otto1, U Cuntz, E Fruehauf, R Wawarta, C Folwaczny, R L Riepl, M L Heiman, P Lehnert, M Fichter, M Tschöp.   

Abstract

OBJECTIVE: Ghrelin is a new gastric hormone that has been identified as an endogenous ligand for the growth hormone (GH) secretagogue receptor subtype 1a (GHS-R1a). Ghrelin administration however not only stimulates GH secretion but also induces adiposity in rodents by increasing food intake and decreasing fat utilization. We hypothesized that impaired ghrelin secretion in anorexia nervosa may be involved in the pathogenesis of this eating disorder. To examine this hypothesis and to further investigate the role for ghrelin in regulating energy homeostasis, we analyzed circulating ghrelin levels in patients with anorexia nervosa and examined possible correlations with clinical parameters before and after weight gain.
METHODS: Plasma ghrelin levels were measured in overnight fasting plasma samples from 36 female patients with anorexia nervosa (age: 25.0+/-1.2 years, BMI: 15.2+/-0.2 kg/m(2)) before and after weight gain following psychotherapeutic treatment intervention in a psychosomatic institution. Plasma ghrelin levels were also measured in fasting plasma samples from 24 age-matched female controls (31+/-1.4 years, BMI: 22.9+/-0.45 kg/m(2)). For quantification of ghrelin levels a commercially available radioimmunoassay (Phoenix Pharmaceuticals, USA) was used.
RESULTS: Fasting plasma ghrelin levels in anorectic patients were significantly higher (1057+/-95 pg/ml) than in normal age-matched female controls (514+/-63 pg/ml n=24, P=0.02). Therapeutic intervention in a psychosomatic institution caused an BMI increase of 14% (P<0.001) leading to a significant decrease in circulating ghrelin levels of 25%, (P=0.001). A significant negative correlation between Deltaghrelin and DeltaBMI was observed (correlation coefficient: -0.47, P=0.005, n=36).
CONCLUSION: We show for the first time that fasting plasma levels of the novel appetite-modulating hormone ghrelin are elevated in anorexia nervosa and return to normal levels after partial weight recovery. These observations suggest the possible existence of ghrelin resistance in cachectic states such as caused by eating disorders. Future studies are necessary to investigate putative mechanisms of ghrelin resistance such as a possible impairment of intracellular ghrelin receptor signaling in pathophysiological states presenting with cachexia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720888

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  133 in total

Review 1.  Clinical application of ghrelin in the field of surgery.

Authors:  Shuji Takiguchi; Kohei Murakami; Yoshitomo Yanagimoto; Akihiro Takata; Yasuhiro Miyazaki; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2014-11-01       Impact factor: 2.549

2.  Plasma ghrelin levels and malnutrition: a comparison of two etiologies.

Authors:  M Krsek; M Rosická; H Papezová; J Krízová; E Kotrlíková; M Haluz'k; V Justová; Z Lacinová; Z Jarkovská
Journal:  Eat Weight Disord       Date:  2003-09       Impact factor: 4.652

Review 3.  Peripheral regulation of food intake: new insights.

Authors:  O Ukkola
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

4.  Low prevalence of obesity in Behçet's disease is associated with high obestatin level.

Authors:  Süleyman Serdar Koca; Murat Kara; Metin Özgen; Ramazan Dayanan; Caner Feyzi Demir; Kader Aksoy; Nevin İlhan; Emir Dönder; Ahmet Işık
Journal:  Eur J Rheumatol       Date:  2017-06-01

5.  Plasma des-acyl and acyl ghrelin in patients with eating disorders.

Authors:  T Uehara; I Omori; K Nakamura; M Suda; Y Hosoda; T Minegishi; M Mikuni; K Kangawa
Journal:  Eat Weight Disord       Date:  2005-12       Impact factor: 4.652

6.  A prospective study of serum ghrelin levels in patients treated with clozapine.

Authors:  F M Theisen; S Gebhardt; T Brömel; B Otto; W Heldwein; M Heinzel-Gutenbrunner; J-C Krieg; H Remschmidt; M Tschöp; J Hebebrand
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

7.  Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome.

Authors:  A Gambineri; U Pagotto; M Tschöp; V Vicennati; E Manicardi; A Carcello; M Cacciari; R De Iasio; R Pasquali
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

8.  Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment.

Authors:  Sven Röjdmark; Jan Calissendorff; Olle Danielsson; Kerstin Brismar
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

9.  Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans.

Authors:  Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Matthias H Tschöp; David D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2013-04-15       Impact factor: 5.958

Review 10.  Ghrelin forms in the modulation of energy balance and metabolism.

Authors:  Gianluca Gortan Cappellari; Rocco Barazzoni
Journal:  Eat Weight Disord       Date:  2018-10-24       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.